Edwards Lifesciences Corp (EW)vsReWalk Robotics Ltd (LFWD)
EW
Edwards Lifesciences Corp
$85.96
-1.70%
HEALTHCARE · Cap: $49.01B
LFWD
ReWalk Robotics Ltd
$7.28
-5.21%
HEALTHCARE · Cap: $19.71M
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 30027% more annual revenue ($6.30B vs $20.92M). EW leads profitability with a 17.4% profit margin vs -123.7%. EW earns a higher WallStSmart Score of 61/100 (C+).
EW
Buy61
out of 100
Grade: C+
LFWD
Avoid23
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+68.7%
Fair Value
$253.29
Current Price
$85.96
$167.33 discount
Intrinsic value data unavailable for LFWD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 31.2%
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
16.7% revenue growth
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
0.0% earnings growth
Smaller company, higher risk/reward
Elevated debt levels
ROE of -209.1% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 17.4% and operating margin at 31.2%. Revenue growth of 16.7% demonstrates continued momentum.
Bull Case : LFWD
The strongest argument for LFWD centers on Price/Book.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 46.0x leaves little room for execution misses.
Bear Case : LFWD
The primary concerns for LFWD are EPS Growth, Market Cap, Debt/Equity.
Key Dynamics to Monitor
EW profiles as a growth stock while LFWD is a turnaround play — different risk/reward profiles.
EW carries more volatility with a beta of 0.87 — expect wider price swings.
EW is growing revenue faster at 16.7% — sustainability is the question.
LFWD generates stronger free cash flow (-4M), providing more financial flexibility.
Bottom Line
EW scores higher overall (61/100 vs 23/100), backed by strong 17.4% margins and 16.7% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →ReWalk Robotics Ltd
HEALTHCARE · MEDICAL DEVICES · USA
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company is headquartered in Yokneam Illit, Israel.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?